Article info
PDFLaboratory science - Scientific reports
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
- Correspondence to: Dr G A Peyman Department of Ophthalmology, University of Arizona, 655 N Alvernon Way, Ste 108, Tucson, AZ 85711, USA; ccole{at}eyes.arizona.edu
Citation
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
Publication history
- Accepted December 9, 2006
- First published December 19, 2006.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 British Journal of Ophthalmology